{"id":999690,"date":"2026-09-02T07:03:51","date_gmt":"2026-09-02T11:03:51","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-announces-participation-at-upcoming-investor-conferences-and-scientific-meeting\/"},"modified":"2026-09-02T07:03:51","modified_gmt":"2026-09-02T11:03:51","slug":"eyepoint-announces-participation-at-upcoming-investor-conferences-and-scientific-meeting","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-announces-participation-at-upcoming-investor-conferences-and-scientific-meeting\/","title":{"rendered":"EyePoint Announces Participation at Upcoming Investor Conferences and Scientific Meeting"},"content":{"rendered":"<div class=\"mw_release\">\n<p>WATERTOWN, Mass., Sept.  02, 2026  (GLOBE NEWSWIRE) &#8212; EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that the Company will participate at the following upcoming conferences:<\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:8pt\">\n          <strong>Citi 2026 Biopharma Back to School Conference<\/strong><br \/>\n          <br \/>Forum: Fireside Chat<br \/>Date: September 9, 2026<br \/>Time: 8:00 am ET<\/li>\n<li style=\"margin-bottom:8pt\">\n          <strong>Cantor Global Healthcare Conference 2026<\/strong><br \/>\n          <br \/>Forum: Fireside Chat<br \/>Date: September 10, 2026<br \/>Time: 10:20 am ET<\/li>\n<li style=\"margin-bottom:8pt\">\n          <strong>Morgan Stanley Global Healthcare Conference\u00a0<\/strong><br \/>\n          <br \/>Forum: Fireside Chat<br \/>Date: September 15, 2026<br \/>Time: 7:00 am ET<\/li>\n<\/ul>\n<p>A webcast and subsequent archived replay of each fireside chat at the Investor Conferences may be accessed via the Investors section of the Company website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zVs-uJ7OcH4qivSOR-sXaZjEZEmEytajapiTTbhdLvitwBltrWo2pm9fmNusN6416_kD9zijyj9-3iB8ST1gTx-mpPbJZ1w_PNS5d520aF_Kx8RsBXyK7Gd0Rno5aLXmyKDSb1mBAy8wAEms3xmsg_zxvMs4XfrCASUN8VQ1R5eV_BUXuUWCNm5f-SL7_shcCo0VaT1Cr6_oYejDZeNFu6kxKzUHmx-0qT0Rva-mkMDL7BMhMWIo8vUSqXuJBaca8BMta7g9w8d8tuFcjjLqig==\" rel=\"nofollow\" target=\"_blank\">www.eyepoint.bio<\/a>.<\/p>\n<p><strong>Scientific Meeting<br \/><\/strong>EyePoint will be participating at The Retina Society 59th Annual Scientific Meeting from September 23-26, 2026, in Los Angeles, CA.<\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:8pt\">\n          <strong>Presentation: <\/strong>Bioerodible EYP-1901 (Vorolanib Intravitreal Insert) for Sustained Release of a Tyrosine Kinase Inhibitor for Retinal Exudative Disease: Mechanism of Action and Pharmacokinetic Characteristics<br \/><strong>Presenter: <\/strong>Ehsan Rahimy, M.D. <br \/><strong>Date &amp; Time (Session): <\/strong>September 24, 2026 | 11:15 AM PT (AMD I)<\/li>\n<li style=\"margin-bottom:8pt\">\n          <strong>Presentation: <\/strong>LUGANO Phase 3 Trial of Bioerodible EYP-1901 (Vorolanib Intravitreal Insert) vs Aflibercept in Patients with Neovascular Age-Related Macular Degeneration\u00a0(nAMD): First-Time Vision and Anatomic Outcomes<br \/><strong>Presenter: <\/strong>Carl D. Regillo,\u00a0M.D., FACS, FASRS<br \/><strong>Date &amp; Time (Session): <\/strong>September 24, 2026 | 11:18 AM PT (AMD I)<\/li>\n<li style=\"margin-bottom:8pt\">\n          <strong>Presentation: <\/strong>LUGANO Phase 3 Trial of Bioerodible EYP-1901 (vorolanib intravitreal insert) vs Aflibercept in Patients with Neovascular Age-Related Macular Degeneration (nAMD): First-Time Safety and Treatment Burden Outcomes<br \/><strong>Presenter: <\/strong>Charles C. Wykoff, M.D., Ph.D.<br \/><strong>Date &amp; Time (Session): <\/strong>September 24, 2026 | 11:23 AM PT (AMD I)<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li style=\"margin-bottom:8pt\">\n          <strong>Presentation: <\/strong>Association\u00a0Between\u00a0Central Subfield Thickness\u00a0(CST)\u00a0Fluctuation\u00a0and\u00a0Visual Acuity (VA)\u00a0Outcomes in\u00a0Patients with\u00a0Neovascular\u00a0Age-Related Macular Degeneration (nAMD): An IRIS<sup>\u00ae<\/sup> Registry Analysis<br \/><strong>Presenter: <\/strong>Durga S. Borkar, MD, MMCi<br \/><strong>Date &amp; Time (Session): <\/strong>September 25, 2026 | 3:45 PM PT (AMD III)<\/li>\n<\/ul>\n<p>Presentations from The Retina Society will be available in the Scientific Publications section of the Company website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zVs-uJ7OcH4qivSOR-sXaTWZ2Lq0ThuI-F1fCEWLT_P-I_wpA05CbBH2801UvFREYJ-42yh2oHO5Y_h5tHIyEB0BsVSBMDN5yCkDGjdkYSI=\" rel=\"nofollow\" target=\"_blank\">www.eyepoint.bio<\/a>.<\/p>\n<p>\n        <strong>About EyePoint<\/strong>\n      <\/p>\n<p>EyePoint, Inc. (Nasdaq: EYPT) is a clinical-stage biopharmaceutical company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases. The Company\u2019s lead product candidate, DURAVYU\u2122, is an innovative investigational sustained delivery treatment for serious retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor, in next-generation bioerodible Durasert E\u2122 technology. Supported by robust safety and efficacy data across multiple clinical trials and indications, DURAVYU is currently being evaluated in Phase 3 pivotal trials for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME).<\/p>\n<p>The Company is committed to partnering with the retinal community to improve patient lives while creating long-term value, with four approved drugs over three decades and tens of thousands of eyes treated with EyePoint innovation.<\/p>\n<p>EyePoint is headquartered in Watertown, Massachusetts, with a commercial manufacturing facility in Northbridge, Massachusetts.<\/p>\n<p>Vorolanib is licensed to EyePoint exclusively by Equinox Sciences, a Betta Pharmaceuticals affiliate, for the localized treatment of all ophthalmic diseases outside of China, Macao, Hong Kong and Taiwan.<\/p>\n<p>\n        <em>DURAVYU<\/em><br \/>\n        <sup><br \/>\n          <em>\u2122<\/em><br \/>\n        <\/sup><br \/>\n        <em> has been conditionally accepted by the FDA as the proprietary name for EYP-1901. DURAVYU is an investigational product; it has not been approved by the FDA. FDA approval and the timeline for potential approval is uncertain.<\/em>\n      <\/p>\n<p>\n        <strong>Investors:<\/strong><br \/>\n        <br \/>Robin Garner<br \/>EyePoint, Inc.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=h9PrXko-PFi06rRBmAHocOxqiabaNv_H4_flWNYaZphO7R5hT4L2qMUkJQ8JTJF4z-kIkXiSWKawBQ3l-iZ1aiXDdg4mz_zMaFXu1lOhRVU=\" rel=\"nofollow\" target=\"_blank\">ir@eyepoint.bio<\/a><\/p>\n<p>\n        <strong>Media:<\/strong><br \/>\n        <br \/>Helen O\u2019Gorman<br \/>FTI Consulting<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Jn434puMHSbQxDIYZTTtPBR-CjPjmB-MBKfMyajZMNSQzxaOweG4zEOKHRKzm1CabhJwmIuBCjtJyS4o_wXiVzIwncqBEp6CZ5biJxEGv3k=\" rel=\"nofollow\" target=\"_blank\">media@eyepoint.bio<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxOTk5NyM3ODE0MjY1IzIwMDU4MTc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YTJkOWU2OWMtZWJjYS00ZmNmLWEzMWItMGVmZGM1NDk0MDg5LTEwMTczOTAtMjAyNi0wOS0wMi1lbg==\/tiny\/EyePoint-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WATERTOWN, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) &#8212; EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that the Company will participate at the following upcoming conferences: Citi 2026 Biopharma Back to School Conference Forum: Fireside ChatDate: September 9, 2026Time: 8:00 am ET Cantor Global Healthcare Conference 2026 Forum: Fireside ChatDate: September 10, 2026Time: 10:20 am ET Morgan Stanley Global Healthcare Conference\u00a0 Forum: Fireside ChatDate: September 15, 2026Time: 7:00 am ET A webcast and subsequent archived replay of each fireside chat at the Investor Conferences may be accessed via the Investors section of the Company website at\u00a0www.eyepoint.bio. Scientific MeetingEyePoint will be participating at The &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-announces-participation-at-upcoming-investor-conferences-and-scientific-meeting\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;EyePoint Announces Participation at Upcoming Investor Conferences and Scientific Meeting&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-999690","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>EyePoint Announces Participation at Upcoming Investor Conferences and Scientific Meeting - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-announces-participation-at-upcoming-investor-conferences-and-scientific-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EyePoint Announces Participation at Upcoming Investor Conferences and Scientific Meeting - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WATERTOWN, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) &#8212; EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that the Company will participate at the following upcoming conferences: Citi 2026 Biopharma Back to School Conference Forum: Fireside ChatDate: September 9, 2026Time: 8:00 am ET Cantor Global Healthcare Conference 2026 Forum: Fireside ChatDate: September 10, 2026Time: 10:20 am ET Morgan Stanley Global Healthcare Conference\u00a0 Forum: Fireside ChatDate: September 15, 2026Time: 7:00 am ET A webcast and subsequent archived replay of each fireside chat at the Investor Conferences may be accessed via the Investors section of the Company website at\u00a0www.eyepoint.bio. Scientific MeetingEyePoint will be participating at The &hellip; Continue reading &quot;EyePoint Announces Participation at Upcoming Investor Conferences and Scientific Meeting&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-announces-participation-at-upcoming-investor-conferences-and-scientific-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-02T11:03:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxOTk5NyM3ODE0MjY1IzIwMDU4MTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-announces-participation-at-upcoming-investor-conferences-and-scientific-meeting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-announces-participation-at-upcoming-investor-conferences-and-scientific-meeting\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"EyePoint Announces Participation at Upcoming Investor Conferences and Scientific Meeting\",\"datePublished\":\"2026-09-02T11:03:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-announces-participation-at-upcoming-investor-conferences-and-scientific-meeting\\\/\"},\"wordCount\":546,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-announces-participation-at-upcoming-investor-conferences-and-scientific-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxOTk5NyM3ODE0MjY1IzIwMDU4MTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-announces-participation-at-upcoming-investor-conferences-and-scientific-meeting\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-announces-participation-at-upcoming-investor-conferences-and-scientific-meeting\\\/\",\"name\":\"EyePoint Announces Participation at Upcoming Investor Conferences and Scientific Meeting - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-announces-participation-at-upcoming-investor-conferences-and-scientific-meeting\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-announces-participation-at-upcoming-investor-conferences-and-scientific-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxOTk5NyM3ODE0MjY1IzIwMDU4MTc=\",\"datePublished\":\"2026-09-02T11:03:51+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-announces-participation-at-upcoming-investor-conferences-and-scientific-meeting\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-announces-participation-at-upcoming-investor-conferences-and-scientific-meeting\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-announces-participation-at-upcoming-investor-conferences-and-scientific-meeting\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxOTk5NyM3ODE0MjY1IzIwMDU4MTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxOTk5NyM3ODE0MjY1IzIwMDU4MTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-announces-participation-at-upcoming-investor-conferences-and-scientific-meeting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EyePoint Announces Participation at Upcoming Investor Conferences and Scientific Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EyePoint Announces Participation at Upcoming Investor Conferences and Scientific Meeting - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-announces-participation-at-upcoming-investor-conferences-and-scientific-meeting\/","og_locale":"en_US","og_type":"article","og_title":"EyePoint Announces Participation at Upcoming Investor Conferences and Scientific Meeting - Market Newsdesk","og_description":"WATERTOWN, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) &#8212; EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that the Company will participate at the following upcoming conferences: Citi 2026 Biopharma Back to School Conference Forum: Fireside ChatDate: September 9, 2026Time: 8:00 am ET Cantor Global Healthcare Conference 2026 Forum: Fireside ChatDate: September 10, 2026Time: 10:20 am ET Morgan Stanley Global Healthcare Conference\u00a0 Forum: Fireside ChatDate: September 15, 2026Time: 7:00 am ET A webcast and subsequent archived replay of each fireside chat at the Investor Conferences may be accessed via the Investors section of the Company website at\u00a0www.eyepoint.bio. Scientific MeetingEyePoint will be participating at The &hellip; Continue reading \"EyePoint Announces Participation at Upcoming Investor Conferences and Scientific Meeting\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-announces-participation-at-upcoming-investor-conferences-and-scientific-meeting\/","og_site_name":"Market Newsdesk","article_published_time":"2026-09-02T11:03:51+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxOTk5NyM3ODE0MjY1IzIwMDU4MTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-announces-participation-at-upcoming-investor-conferences-and-scientific-meeting\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-announces-participation-at-upcoming-investor-conferences-and-scientific-meeting\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"EyePoint Announces Participation at Upcoming Investor Conferences and Scientific Meeting","datePublished":"2026-09-02T11:03:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-announces-participation-at-upcoming-investor-conferences-and-scientific-meeting\/"},"wordCount":546,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-announces-participation-at-upcoming-investor-conferences-and-scientific-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxOTk5NyM3ODE0MjY1IzIwMDU4MTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-announces-participation-at-upcoming-investor-conferences-and-scientific-meeting\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-announces-participation-at-upcoming-investor-conferences-and-scientific-meeting\/","name":"EyePoint Announces Participation at Upcoming Investor Conferences and Scientific Meeting - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-announces-participation-at-upcoming-investor-conferences-and-scientific-meeting\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-announces-participation-at-upcoming-investor-conferences-and-scientific-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxOTk5NyM3ODE0MjY1IzIwMDU4MTc=","datePublished":"2026-09-02T11:03:51+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-announces-participation-at-upcoming-investor-conferences-and-scientific-meeting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-announces-participation-at-upcoming-investor-conferences-and-scientific-meeting\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-announces-participation-at-upcoming-investor-conferences-and-scientific-meeting\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxOTk5NyM3ODE0MjY1IzIwMDU4MTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxOTk5NyM3ODE0MjY1IzIwMDU4MTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-announces-participation-at-upcoming-investor-conferences-and-scientific-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"EyePoint Announces Participation at Upcoming Investor Conferences and Scientific Meeting"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/999690","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=999690"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/999690\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=999690"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=999690"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=999690"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}